Search results for PX-TA1008

Ranibizumab Biosimilar – Anti-VEGF mAb – Research Grade, ProteoGenix, PX-TA1008

Description of Ranibizumab Biosimilar - Anti-VEGF mAb - Research Grade General information about Ranibizumab Ranibizumab is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the “wet” type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion. This product is for research use only.